Overview

Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa

Status:
Terminated

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

Summary

The study will be conducted in asymptomatic pregnant women with P. falciparum parasitemia. The subjects will be given 3 day dosing regiment of the fixed-dose combination of Azithromycin and Chloroquine. Parasitological clearance rate with polymerase chain reaction data will be evaluated on Day 28 as primary endpoint.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Azithromycin
Chloroquine
Chloroquine diphosphate